论文部分内容阅读
目的 :探讨倍他乐克在慢性心力衰竭中的治疗作用及合适剂量。方法 :选择不同病因慢性心衰患者共 40例 ,在常规强心、利尿、扩血管药物治疗基础上 ,加用倍他乐克 ,缓慢递增剂量 ,8周后评估其临床有效性及安全剂量。结果 :40例中 ,32例心功能提高 1级以上 ,有效率 80 % ,倍他乐克耐受量为高心病最大 ,心肌病最小。结论 :在常规抗心衰药物治疗基础上加用倍他乐克安全有效 ,病因不同 ,剂量有别。
Objective: To explore the therapeutic effect of Betaloc in chronic heart failure and its suitable dosage. Methods: A total of 40 patients with chronic heart failure of different etiologies were enrolled in this study. Betaloc on the basis of conventional cardioplegic, diuretic and vasodilator drugs was administered. The clinical efficacy and safety dose were assessed after 8 weeks. Results: Among the 40 cases, the cardiac function of 32 cases was improved by more than one grade, the effective rate was 80%. Beta- Conclusion: It is safe and effective to add Betaloc on the basis of routine anti-heart failure drug treatment, with different etiologies and doses.